Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-03-15 @ 10:07 PM
Study NCT ID:
NCT01308294
Status:
TERMINATED
Last Update Posted:
2020-06-11
First Post:
2011-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients
Sponsor:
Centre Hospitalier Universitaire Vaudois
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
P009-2010DR1082
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |